Skip to content

Acetazolamide

Published: July 26, 2026Updated: August 24, 2026

Acetazolamide is a carbonic anhydrase inhibitor that reduces fluid production in the eye, making it effective for managing elevated intraocular pressure. It is primarily prescribed for certain types of glaucoma and is also used off-label for altitude sickness prevention and as an adjunct in seizure disorders.

Quick summary

Acetazolamide is an eye pressure-reducing medication primarily used to treat glaucoma by inhibiting aqueous humor production.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 24, 2026Editorial policy

Key facts at a glance

ATC
S01EC01
RxNorm
167
Generic
Acetazolamide
Class
atc-s01
Brands
—
Availability
rx
Lactation
unknown
Routes
oral
Forms
capsule, tablet, injection
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Dosage and administration

adult (standard)tablet
Usual dose
500mg twice daily
Maximum
consult physician
Frequency
every 12 hours
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
pediatric (standard)tablet
Usual dose
250mg twice daily
Maximum
consult physician
Frequency
every 12 hours
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
geriatric (standard)tablet
Usual dose
400mg daily
Maximum
consult physician
Frequency
once daily
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard

Overdose information

Important overdose information
Toxic dose: Single dose of approximately 10g or more may cause serious toxicity in adults
Chronic overdose: Prolonged use at high doses can lead to cumulative toxicity including metabolic acidosis and electrolyte imbalances
Immediate actions
Gastric lavage may be considered if ingestion within 1-2 hours. Activate charcoal. Monitor electrolytes, acid-base status, and renal function. Provide supportive care including IV fluids and electrolyte replacement.
Antidote
No specific antidote exists(N/A - treatment is supportive)
Poison Control: 1-800-222-1222

Special Populations

9 groups
✗

pregnancy

first trimester
unsafe
FDA Category
C
Dose Adjustment

avoid if possible

Key Recommendations

avoid use during pregnancy unless benefits outweigh risks

Monitor

regular fetal monitoring

Use of this medication in this population requires careful consideration of risks and benefits.

⚠

pregnancy

second trimester
caution
FDA Category
C
Dose Adjustment

use only if clearly needed

Key Recommendations

use only if benefits outweigh potential risks to fetus

Monitor

regular prenatal monitoring

Use with caution and monitor for adverse effects.

⚠

pregnancy

third trimester
caution
FDA Category
C
Dose Adjustment

use only if clearly needed

Key Recommendations

use only if benefits outweigh potential risks

Monitor

fetal and maternal monitoring

Use with caution and monitor for adverse effects.

⚠

lactation

breastfeeding
caution
FDA Category
C
Dose Adjustment

use with caution

Key Recommendations

use only if benefits outweigh risks to infant

Monitor

monitor infant for side effects

Use with caution and monitor for adverse effects.

⚠

pediatric_age

general
caution
FDA Category
C
Dose Adjustment

weight-based dosing required

Key Recommendations

use with caution in children; not recommended for extended use

Monitor

monitor growth and development

Use with caution and monitor for adverse effects.

✗

renal_impairment

severe
contraindicated
FDA Category
C
Dose Adjustment

contraindicated

Key Recommendations

do not use in patients with severe renal impairment

Monitor

not applicable

Use of this medication in this population requires careful consideration of risks and benefits.

⚠

renal_impairment

moderate
caution
FDA Category
C
Dose Adjustment

reduce dose

Key Recommendations

reduce dose and monitor renal function

Monitor

regular renal function monitoring

Use with caution and monitor for adverse effects.

⚠

hepatic_impairment

general
caution
FDA Category
C
Dose Adjustment

use with caution

Key Recommendations

use with caution; monitor for adverse effects

Monitor

monitor liver function

Use with caution and monitor for adverse effects.

⚠

geriatric

general
caution
FDA Category
C
Dose Adjustment

no specific adjustment

Key Recommendations

use with caution; start at lower end of dosing range

Monitor

monitor for side effects and renal function

Use with caution and monitor for adverse effects.

Statistics and clinical data

prescribingFDA
2023

Commonly prescribed since

Value:1950s

FDA approval year for Acetazolamide

drug_classWHO
2023

Drug class

Value:Carbonic anhydrase inhibitor

Pharmacological classification based on mechanism of action

usageMedical guidelines
2023

Common uses

Value:Glaucoma, altitude sickness, epilepsy, diuretic

Primary therapeutic applications

mechanismPharmacology references
2023

Mechanism of action

Value:Carbonic anhydrase inhibition

Primary pharmacological mechanism

Treats open-angle glaucoma and secondary glaucoma by lowering intraocular pressure; also used for acute altitude sickness prophylaxis and as adjunctive therapy for certain seizure disorders.

Inhibits carbonic anhydrase enzyme in the ciliary body of the eye, reducing the production of aqueous humor and thereby decreasing intraocular pressure.

May cause metabolic acidosis, hypokalemia, paresthesias, and taste alterations; contraindicated in sulfonamide allergy and severe renal/hepatic impairment; oral formulation available as alternative when topical glaucoma agents are insufficient.

Contraindications

Conditions and patient states where this medication should be avoided or used with caution.

Do not use (1)

ABSOLUTEhypersensitivity

Known allergy to this medication or its components

Use caution (1)

RELATIVEpregnancy

Consult healthcare provider for benefits vs risks assessment

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 24, 2026. · Read our editorial policy